NFKB1 and urinary bladder carcinoma: LINC00467 can activate the NF-κB signaling pathway to promote the occurrence and development of bladder cancer, and can be used as a potential target for bladder cancer treatment, thus providing new ideas for targeted therapy of bladder cancer.